Riamilovir is an antiviral drug whose activity is primarily directed against RNA viruses. Riamilovir acts directly on the viruss RNA-dependent RNA polymerase, thereby preventing the virus from replicating. This mechanism allows Riamilovir to effectively reduce the amount of virus, accelerate the relief of symptoms, and help reduce the severity of the disease. Riamilovir can be used in the study of acute respiratory viral infections caused by new variants of SARS-CoV-2[1].
Molekulargewicht:
228.19
CAS Nummer:
[123606-06-4]
Formel:
C5H4N6O3S
Target-Kategorie:
SARS-CoV
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
